24683-20-3,
UNII-KN712V27AV,
Saccharin N-(2-acetic acid ethyl ester),
Ethyl (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate,
KN712V27AV,
ethyl (1,1-dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetate,
ethyl 2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetate,
Saccharin N-(2-Acetic Acid Ethyl Ester)(Piroxicam Impurity E),
(1,1,3-Trioxo-1,3-dihydro-1lambda*6*-benzo[d]isothiazol-2-yl)-acetic acid ethyl,
Piroxicam impurity E [EP],
Piroxicam Impurity E,
AC1LCV0O,
(Piroxicam Impurity E)",
ChemDiv1_000366,
EC 607-416-7,
Oprea1_631494,
Oprea1_858121,
CHEMBL3125563,
SCHEMBL14884779,
CTK8G3035,
HMS588A14,
DTXSID50179412,
YKCQHUPTHHPHGX-UHFFFAOYSA-N,
HMS3429B03,
ZINC297517,
BBL023194,
Ethyl2,3-dihydro-3-oxo-1,2-benzisothiazole-2-acetate-1,1-dioxide,
MFCD00688886,
STK136579,
1,2-Benzisothiazole-2(3H)-acetic acid, 3-oxo-, ethyl ester, 1,1-dioxide,
AKOS000418951,
CCG-113731,
MCULE-1359837935,
BAS 00398440,
FT-0674495,
ST50227434,
T7571,
SR-01000398864,
SR-01000398864-1,
ethyl 2-(1,1,3-trioxo-2-hydrobenzo[d]isothiazol-2-yl)acetate,
Benzo[d]isothiazol-3-one, 2-(2-ethoxy-2-oxoethyl)-, 1,1-dioxide,
Ethyl (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate #,
Ethyl 2-(1,1-dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)acetate,
3-Oxo-1,2-benzisothiazole-2(3H)-acetic Acid Ethyl Ester 1,1-Dioxide,
ethyl 2-(1,1,3-trioxo-2,3-dihydro-1lambda6,2-benzothiazol-2-yl)acetate,
C11H11NO5S,
CID607195,
ZINC00297517,